Royalty Pharma plc SEC filings RPRX
Royalty Pharma plc has 636 filings in SEC EDGAR's recent list, going back to Feb 13, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 28, 2026 | May 22, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2026 | Apr 13, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 22, 2025 | Dec 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 22, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 16, 2025 | Sep 16, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2025 | Jul 17, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Officer or director change, Bylaw or fiscal year change
|
May 19, 2025 | May 16, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Material agreement
|
Apr 11, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2025 | Apr 7, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Dec 31, 2024 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 7, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Other events
|
Jun 20, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 10, 2024 | Jun 10, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Material agreement
|
Jun 4, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Other events
|
May 29, 2024 | May 29, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Other events
|
Feb 6, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 27, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Other events
|
Dec 27, 2023 | Dec 27, 2023 |
| 8-K |
Current report
Other events
|
Nov 16, 2023 | Nov 16, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
New debt
|
Oct 19, 2023 | Oct 18, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 28, 2023 | Mar 24, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2023 | Feb 15, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Impairment
|
Dec 1, 2022 | Dec 1, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Other events
|
Jul 13, 2022 | Jul 13, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 17, 2022 | May 17, 2022 |
| 8-K |
Current report
Other events
|
May 11, 2022 | May 10, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Other events
|
Apr 15, 2022 | Apr 15, 2022 |
| 8-K |
Current report
Auditor change
|
Apr 4, 2022 | Apr 1, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 26, 2021 | Jul 26, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 16, 2021 | Jul 15, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2021 | Jun 24, 2021 |
| 8-K |
Current report
Other events
|
Jun 2, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 17, 2021 | Feb 17, 2021 |
| 8-K |
Current report
Other events
|
Feb 3, 2021 | Feb 3, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Material agreement
|
Nov 5, 2020 | Oct 30, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 2, 2020 | Sep 2, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 19, 2020 | Aug 19, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2020 | Aug 12, 2020 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 3, 2020 | Jul 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 3, 2020 | Jul 30, 2020 |
| 8-K |
Current report
Results of operations
|
Jul 14, 2020 | Jul 14, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
|
Jun 19, 2020 | Jun 16, 2020 |
Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RPRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1802768
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.